Andrew Harmos

Andrew Harmos
Director

Andrew, one of the firm’s two serving co-founders, advises on a wide range of corporate transactions, with a focus on takeovers, corporate advisory, co-investment and joint venture arrangements, and business acquisitions and divestments.

He has particular expertise in providing strategic board, governance and transaction advice, and is regularly asked to provide specialist independent advice to boards in tandem with a company’s usual legal advisers. He is the lead legal adviser to a number of NZX listed entities including Abano Healthcare Group, Argosy Property, Green Cross Health, and Vital Healthcare Property Trust, and a specialist advisor to a number of other NZX 5O companies.

Andrew is recognised as one of New Zealand’s leading public takeover lawyers, and co-heads the firm’s takeover practice. His experience and expertise in advising on the defence of hostile or unsolicited bids is unrivalled, and he is often sought out to provide specialist governance and strategic advice to boards who receive unsolicited bid proposals. He has presented on takeover defence to the New Zealand Institute of Directors Chairman’s Group and other specialist bodies.

Andrew was a senior corporate partner at Russell McVeagh before he left that firm in 2002 to establish Harmos Horton Lusk.

Recognition

Andrew is ranked as a Band 1 individual for Corporate/Commercial by Chambers Global and Chambers Asia Pacific, and is described as “world class and very strategic” with “an ‘excellent reputation’ in the corporate governance and transactional spheres, especially where complex takeover matters are concerned”.

Andrew is also recognised as a leading individual for Corporate/M&A by Asia Pacific Legal 500, with clients noting that he is “incredibly intelligent and always thinking of ways to achieve the required outcome”. In addition, he is recognised as a leading lawyer for Corporate/M&A by Asia Law Profiles and individually ranked for M&A by IFLR 1000.

Governance and other roles

Andrew has extensive governance experience across the listed, unlisted and not for profit sectors in New Zealand. He is the former chair of the board of NZX, and is a non-executive director of ASX listed Scentre Group and of AMP Life Limited in Australia. In addition, he is a director of two private companies (farm ownership and investment management) with external shareholders.

Recent disclosable transactions: 
1

Advised NZX Main Board listed Hellaby Holdings on its response to a $352 million full cash takeover offer from ASX listed Bapcor

2016/2017
2

Advised NZX Main Board listed Abano Healthcare Group on its defence of an unsolicited partial takeover offer which valued the company at $215 million

2016/2017
3

Advised the board of NZX Main Board/ASX listed The a2Milk Company Limited in a specialist adviser role on its defence of an unsolicited takeover approach

2016
4

Advised Vital Healthcare Management as manager of NZX Main Board listed Vital Healthcare Property Trust on its underwritten $160 million renounceable rights issue

2016
5

Advised the independent directors of NZAX listed Pulse Energy on their response to a full takeover offer from Buller Electricity

2015/2016
6

Advised New Zealand’s largest meat co-operative, Silver Fern Farms, on the $260 million investment by Shanghai Maling into a new joint venture entity to be established between Silver Fern Farms and Shanghai Maling

2015/2016
7

Advised USA based Calera Capital on the acquisition of a cornerstone shareholding in Transaction Services Group

2015
8

Advised NZX Main Board listed Pacific Edge on the negotiation of a settlement agreement with the Financial Markets Authority to settle certain alleged breaches of NZX continuous disclosure obligations

2015

World class and very strategic with an ‘excellent reputation’ in the corporate governance and transactional spheres, especially where complex takeover matters are concerned.

- Chambers Global 2016 and Chambers Asia Pacific 2016